Pharma Focus Asia

One Key

Cegedim Relationship Management is pleased to update you on the progress of data optimization services in China.

With the release of the new healthcare reform plan in early April 2009, China is at a turning point. After many years of unequal medical access for the country?s poor, rural majority, which resulted in outbreaks of social unrest in recent years, the Chinese government has announced healthcare reform plans costing US $124bn over three years.

The China?s healthcare reform establishes a clear course, but the implications for healthcare players are not so obvious. On one hand, the healthcare sector will grow significantly. On the other hand, the government is encouraging patients to shift from urban hospitals to grassroots healthcare providers, and an important share of healthcare expenditure with it.

All these tremendous evolutions of the national healthcare system generate an impressive turnover, resulting in a really important need of support in the management of the data. With daily updates and constant validation services, OneKey Data Solution is set to answer to the current challenges of the market.

Download '.pdf' Format of the whitepaper.

Download Whitepapers
magazine-slider-imageHexagon - Expert Insights WebinarMFA + MMA 20244th Annual Cleaning Validation 20242nd Annual Pharma Impurity Conclave 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference